Back
Blue Hat Interactive Entertainment Technology 10K Form
Buy
67
BHAT
Blue Hat Interactive Entertainment Technology
Last Price:
1.20
Seasonality Move:
-29.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BHAT News And Ratings
See the #1 stock for the next 7 days that we like better than BHAT
BHAT Financial Statistics
Sales & Book Value
| Annual Sales: | $73.69M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.70 |
| Price / Book: | 1.84 |
Profitability
| EPS (TTM): | -0.61570 |
|---|---|
| Net Income (TTM): | $-19.3M |
| Gross Margin: | $1.15M |
| Return on Equity: | -86.78% |
| Return on Assets: | -45.74% |
Blue Hat Interactive Entertainment Technology Earnings Forecast
Key Blue Hat Interactive Entertainment Technology Financial Ratios
- The Gross Profit Margin over the past 7 years for BHAT is 1.57%.
- The Selling, General & Administrative Expenses for BHAT have been equal to 18.69% of Gross Profit Margin.
- The Research & Development expenses have been 3.49% of Revenue.
- The Interest Expense is -1.15% of Operating Income.
- The Net Earning history of BHAT is -26.19% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Blue Hat Interactive Entertainment Technology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Entertainment |
| Sector: | Communication Services |
| Current Symbol: | BHAT |
| Website: | ir.bluehatgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 6.94 |
| Quick Ratio: | 3.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BHAT Technical Analysis vs Fundamental Analysis
Buy
67
Blue Hat Interactive Entertainment Technology (BHAT)
is a Buy
Is Blue Hat Interactive Entertainment Technology a Buy or a Sell?
-
Blue Hat Interactive Entertainment Technology stock is rated a Buy
The current Blue Hat Interactive Entertainment Technology [BHAT] share price is $1.28. The Score for BHAT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.